• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LMO2在前列腺癌及相邻前列腺实质中的表达

Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma.

作者信息

Krušlin Božo, Vučić Majda, Mašić Silvija, Kruljac Ivan, Lež Cvjetko, Ružić Boris, Spajić Borislav, Ulamec Monika

机构信息

Ljudevit Jurak Department of Pathology and Cytology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia.

Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.

出版信息

Acta Clin Croat. 2018 Oct;57(Suppl 1):56-60. doi: 10.20471/acc.2018.57.s1.08.

DOI:10.20471/acc.2018.57.s1.08
PMID:30457249
Abstract

LMO2 (LIM domain only) is a member of transcription factor family of proteins characterized by their cysteine-rich, zinc-binding LIM domains. Its expression in prostate cancer cells, as well as in adjacent stroma, is described in a study in a cohort of 83 patients treated with radical prostatectomy for clinically localized prostate adenocarcinoma. Authors found that LMO2 overexpression in prostate cancer was strongly associated with features indicative of worse prognosis (higher preoperative PSA, higher Gleason score, positive surgical margins, and extraprostatic extension of disease). Expression of LMO2 was also associated with biochemical disease progression. We analysed immunohistochemical expression of LMO2 in prostate cancer epithelial and stromal cells, as well as in adjacent parenchyma. Significant negative correlation between glandular expression of LMO2 in carcinoma and stromal expression in BPH (ρ = -0.238, P = 0.033) was found, but also be-tween stromal expression in carcinomas and glandular expression in BPH (ρ = -0.255, P = 0.021). Positive correlation was found between stromal expression in BPH and stromal expression in carci-nomas (ρ = 0.306, P = 0.005). Study results support the potential role of LMO2 in prostatic carcino-genesis and cancer progression.

摘要

LMO2(仅含LIM结构域)是转录因子蛋白家族的成员,其特征在于富含半胱氨酸的锌结合LIM结构域。在一项针对83例接受根治性前列腺切除术治疗临床局限性前列腺腺癌患者的队列研究中,描述了其在前列腺癌细胞以及相邻基质中的表达情况。作者发现前列腺癌中LMO2的过表达与提示预后较差的特征(术前PSA水平较高、Gleason评分较高、手术切缘阳性以及疾病前列腺外侵犯)密切相关。LMO2的表达还与生化疾病进展有关。我们分析了LMO2在前列腺癌上皮细胞、基质细胞以及相邻实质中的免疫组化表达。发现癌组织中LMO2的腺性表达与良性前列腺增生(BPH)中的基质表达之间存在显著负相关(ρ = -0.238,P = 0.033),癌组织中的基质表达与BPH中的腺性表达之间也存在负相关(ρ = -0.255,P = 0.021)。还发现BPH中的基质表达与癌组织中的基质表达之间存在正相关(ρ = 0.306,P = 0.005)。研究结果支持LMO2在前列腺癌发生和癌症进展中的潜在作用。

相似文献

1
Expression of LMO2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma.LMO2在前列腺癌及相邻前列腺实质中的表达
Acta Clin Croat. 2018 Oct;57(Suppl 1):56-60. doi: 10.20471/acc.2018.57.s1.08.
2
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.局限性和局部晚期前列腺癌的新辅助和辅助激素治疗
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2.
3
Cryotherapy for localised prostate cancer.局部前列腺癌的冷冻疗法。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005010. doi: 10.1002/14651858.CD005010.pub2.
4
Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.系统评价:临床局限性前列腺癌治疗方法的比较效果与危害
Ann Intern Med. 2008 Mar 18;148(6):435-48. doi: 10.7326/0003-4819-148-6-200803180-00209. Epub 2008 Feb 4.
5
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.晚期前列腺癌治疗中早期与延迟雄激素抑制疗法的比较
Cochrane Database Syst Rev. 2002(1):CD003506. doi: 10.1002/14651858.CD003506.
6
Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.腹腔镜及机器人辅助与开放根治性前列腺切除术治疗局限性前列腺癌的比较
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD009625. doi: 10.1002/14651858.CD009625.pub2.
7
[Clinical significance of SLIT2/ROBO1 expression in prostate cancer].[SLIT2/ROBO1表达在前列腺癌中的临床意义]
Zhonghua Bing Li Xue Za Zhi. 2025 Jul 8;54(7):733-740. doi: 10.3760/cma.j.cn112151-20250108-00023.
8
Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.前列腺癌的Gleason分级系统是否应进行修改以纳入高级别三级成分?一项系统评价和荟萃分析。
Lancet Oncol. 2007 May;8(5):411-9. doi: 10.1016/S1470-2045(07)70136-5.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.调强放疗治疗前列腺癌的系统评价和经济评估。
Health Technol Assess. 2010 Oct;14(47):1-108, iii-iv. doi: 10.3310/hta14470.

本文引用的文献

1
Histological and quantitative analyzes of the stromal and acinar components of normal human prostate zones.对正常人类前列腺区基质和腺泡成分的组织学及定量分析。
Prostate. 2018 Mar;78(4):289-293. doi: 10.1002/pros.23472. Epub 2018 Jan 8.
2
LIM domain only 2 over-expression in prostate stromal cells facilitates prostate cancer progression through paracrine of Interleukin-11.仅含LIM结构域蛋白2在前列腺基质细胞中的过表达通过白细胞介素-11的旁分泌促进前列腺癌进展。
Oncotarget. 2016 May 3;7(18):26247-58. doi: 10.18632/oncotarget.8359.
3
LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
仅含LIM结构域蛋白2通过胞质p27(KIP1)诱导胶质瘤侵袭。
Tumour Biol. 2016 Feb;37(2):2473-80. doi: 10.1007/s13277-015-4072-0. Epub 2015 Sep 18.
4
Prostate cancer stroma: an important factor in cancer growth and progression.前列腺癌基质:癌症生长和进展的重要因素。
Bosn J Basic Med Sci. 2015 May 13;15(2):1-8. doi: 10.17305/bjbms.2015.449.
5
Comparative transcriptome analysis between metastatic and non-metastatic gastric cancer reveals potential biomarkers.转移性与非转移性胃癌之间的比较转录组分析揭示了潜在的生物标志物。
Mol Med Rep. 2015 Jan;11(1):386-92. doi: 10.3892/mmr.2014.2709. Epub 2014 Oct 20.
6
LIM-domain-only proteins in cancer.LIM 结构域蛋白与癌症。
Nat Rev Cancer. 2013 Feb;13(2):111-22. doi: 10.1038/nrc3418. Epub 2013 Jan 10.
7
LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.LMO2是一种用于预测胰腺癌更好预后的新型标志物。
Neoplasia. 2009 Jul;11(7):712-9. doi: 10.1593/neo.09418.
8
The significance of LMO2 expression in the progression of prostate cancer.LMO2表达在前列腺癌进展中的意义。
J Pathol. 2007 Feb;211(3):278-85. doi: 10.1002/path.2109.
9
Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.从患病组织与正常组织培养的前列腺基质细胞的独特基因表达。
J Cell Physiol. 2007 Jan;210(1):111-21. doi: 10.1002/jcp.20828.
10
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.癌蛋白LMO2在正常生发中心B细胞和人类B细胞淋巴瘤中表达。
Blood. 2007 Feb 15;109(4):1636-42. doi: 10.1182/blood-2006-08-039024. Epub 2006 Oct 12.